— Know what they know.
Not Investment Advice
Also trades as: TOIIW (NASDAQ) · $vol 0M

TOI NASDAQ

The Oncology Institute, Inc.
1W: -1.2% 1M: -2.8% 3M: +26.7% YTD: +39.8% 1Y: +39.8% 3Y: +440.0% 5Y: -48.6%
$5.13
Last traded 2026-08-03 — delisted
NASDAQ · Healthcare · Medical - Care Facilities · $512.9M mcap · 49M float · 3.89% daily turnover · Short 67% of daily vol
Smart Money Score
Moderate 50
Insider+$0.7M
Congress—
ETF Holdings—
Key Statistics
Market Cap$512.9M
52W Range2.32-7.05
Volume1,212,244
Avg Volume1,924,103
Beta0.42
Dividend—
Analyst Ratings
5 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEODaniel Virnich
Employees641
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2020-06-04
18000 Studebaker Road
Cerritos, CA 90703
US
213 760 1328
About The Oncology Institute, Inc.

The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.

Recent Insider Trades

NameTypeSharesPriceDate
Johnson Karen Marie A-Award 31,124 — 2026-07-27
Kaushal Mohit A-Award 33,133 — 2026-07-27
McGeorge Anne A-Award 41,165 — 2026-07-27
Pacala Mark L A-Award 30,120 — 2026-07-27
STOLPER MARK A-Award 31,124 — 2026-07-27

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms